Skip to main content

Center for Vaccine Development and Global Health (CVD)

Overview

Our faculty and staff are experts in the field of global health and vaccinology, and they are dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world. Our key mission is to harness the power of vaccines to prevent disease and save lives in the most vulnerable populations.

Our research, surveillance and vaccine development focuses on four key areas: Enteric Diseases, Malaria, Influenza and Respiratory Diseases, and Emerging Pathogens.

For over 40 years, our researchers in the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) in Baltimore, MD have worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.

The CVD is an academic enterprise engaged in the full range of infectious disease intervention from basic laboratory research through vaccine development, pre-clinical and clinical evaluation, large-scale pre-licensure field studies, and post-licensure assessments.

Training is a critical component of our work to ensure the foundation for the next generation of scientists and researchers committed to global health initiatives.


Click Here for a full-screen map

GIVE TO CVD

VOLUNTEER FOR CVD TRIALS


Kathleen M. Neuzil, MD, MPH, FIDSA
Director, Center for Vaccine Development and Global Health


Connect with Us


News and Events

Febraury 25, 2020

World Health Organization Names UMSOM Faculty Member as COVID-19 Advisor

Dr. Samba Sow Will Serve as Special Envoy on COVID-19, Bringing Key Expertise on Containing Prior Outbreaks


January 30, 2020

UMSOM Pediatric Infectious Disease Experts Sound Alarm Over Risk of Outbreaks in U.S. Border Detention Centers

UM School of Medicine Experts Cite Urgent Need for Influenza Vaccinations for Detainees to Prevent Outbreaks


December 10, 2019

January 9, 2020

UM School of Medicine Research Shows Less Severe Cases of Diarrheal Illness can Still Lead to Child Deaths, Even Weeks Following Onset of the Illness

Landmark GEMS Research Could Help Set Path to Reduce Child Mortality Linked to Diarrheal Illness


December 10, 2019

UMSOM Researchers to Test Vaccine Designed to Protect Against Serious Illness from Contaminated Food and Water

Dr. Wilbur Chen and Dr. Eileen Barry Will Test a Vaccine Developed at UMSOM, With $4.5 Million in Funding from Emergent BioSolutions


November 20, 2019

Two UM School of Medicine Experts Receive Prestigious 2019 Bailey K. Ashford Medal for Distinguished Work in Tropical Medicine

Dr. Shannon Takala-Harrison is a Leader in Malaria Research and Dr. Sharon Tennant is a Leader in Vaccine Research.